161 papers found
Refreshing results…
Minor dietary effects on HDL in physically active men
The influence of Tigason' (Ro 10–9359) on the serum lipoproteins in man
Serum lipoprotein lipid and apolipoprotein concentrations in grossly obese patients before and after jejuno-ileal shunt operation
2: 45 p.m.: HDL-CHOLESTEROL AND APO A-I CONCENTRATION IN CONDITIONED MIDDLE-AGED MEN WITH LONG TERM ALTERATION IN FAT INTAKE AND WITH DETRAINING:
Treatment of Hyperlipoproteinemia with ‘Type-Specific’ Diets under Metabolic Ward Conditions
Body Weight, Skeletal Muscle Morphology, and Enzyme Activities in Relation to Fasting Serum Insulin Concentration and Glucose Tolerance in 48-year-old Men
Substituting polyunsaturated for saturated fat as a single change in a Swedish diet: effects on serum lipoprotein metabolism and glucose tolerance in patients with hyperlipoproteinaemia
Changes in the fatty acid composition of the plasma lipid esters during lipid-lowering treatment with diet, clofibrate and niceritrol Reduction of the proportion of linoleate by clofibrate but not by niceritrol
Glucose and Lipoprotein Metabolism in Primary Hyperparathyroidism. Effects of Parathyroidectomy
Para-aminosalicylic acid as a lipid-lowering agent
Lipoprotein-lipase activity in human skeletal muscle and adipose tissue in the fasting and the fed states
Lipolytic Activities in Post-Heparin Plasma in Man Measured with Different Substrate Emulsions
Effects of Chenodeoxycholic Acid (CD) Treatment on Endogenous Plasma Triglyceride (TG) Transport in Hyperlipoproteinemia (HLP)
Effect of a Diet Enriched in Polyunsaturated Fatty Acids on Hyperlipoproteinemia in Man
Supplementation with vitamin E in hyperlipidemic patients treated with diet and clofibrate. Effects on serum lipoprotein concentrations, plasma fatty acid composition and adipose tissue lipoprotein lipase activity.
Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen
Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
Serum levels of thyroid-stimulating hormone in hyperlipoproteinemia
Conversion of Type III Hyperlipoproteinaemia to Type IV Hyperlipoproteinemia by a Fat-Free, Carbohydrate Rich Diet
Conversion of Type III Hyperlipoproteinaemia to Type IV Hyperlipoproteinaemia by a Fat-Free, Carbohydrate Rich Diet
Missing publications? Read more about our data sources.